Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in heterogeneity and classification of osteoarthritis.

Bone research·2026
Same author

Transcriptomic Analysis of Tendon Healing Using an Extracellular Matrix-Coated, Polyurethane Scaffold.

Bioengineering (Basel, Switzerland)·2026
Same author

FDA roadmap to reducing animal testing: a regulatory and scientific paradigm shift in nonclinical safety assessment.

Stem cell research & therapy·2026
Same author

Refining Osteoarthritis Risk Prediction: Average Sagittal Abdominal Diameter Complements and Enhances Body Mass Index With Sex-Specific Insights From National Health and Nutrition Examination Survey.

Health care science·2026
Same author

Bioinspired, Mitochondria-Targeted Single-Atom Nanozyme Enhances Bone Regeneration by Reprogramming Stem Cell Energy Metabolism​.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Challenges and opportunities for the use of telehealth in rare disease diagnosis, treatment, research, and education: key opinion leader interviews by the IRDiRC telehealth task force.

Therapeutic advances in rare disease·2026

Related Experiment Video

Updated: Jun 28, 2026

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
10:20

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model

Published on: August 10, 2018

Mesenchymal stem cells in arthritic diseases.

Faye H Chen1, Rocky S Tuan

  • 1Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis, and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Dr, Bethesda, MD 20892, USA. chenf1@mail.nih.gov

Arthritis Research & Therapy
|October 25, 2008
PubMed
Summary

Mesenchymal stem cells (MSCs) offer promising therapeutic potential for osteoarthritis and rheumatoid arthritis due to their regenerative and anti-inflammatory properties. These cells can be used for tissue engineering and directly treating joint diseases.

More Related Videos

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Isolation and Cellular Phenotyping of Mesenchymal Stem Cells Derived from Synovial Fluid and Bone Marrow of Minipigs
10:47

Isolation and Cellular Phenotyping of Mesenchymal Stem Cells Derived from Synovial Fluid and Bone Marrow of Minipigs

Published on: July 2, 2016

Related Experiment Videos

Last Updated: Jun 28, 2026

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
10:20

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model

Published on: August 10, 2018

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Isolation and Cellular Phenotyping of Mesenchymal Stem Cells Derived from Synovial Fluid and Bone Marrow of Minipigs
10:47

Isolation and Cellular Phenotyping of Mesenchymal Stem Cells Derived from Synovial Fluid and Bone Marrow of Minipigs

Published on: July 2, 2016

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Immunology

Background:

  • Mesenchymal stem cells (MSCs) are easily isolated, rapidly growing progenitor cells with differentiation potential, ideal for tissue engineering.
  • Osteoarthritis (OA) and rheumatoid arthritis (RA) involve inflammation and immune responses, hindering cartilage repair.
  • Recent research highlights MSCs' potent immunosuppressive and anti-inflammatory effects.

Purpose of the Study:

  • To review advances in stem cell biology relevant to joint diseases over the past decade.
  • To discuss the role of MSCs in the pathophysiology of degenerative joint diseases.
  • To explore MSC-based cell therapy for OA and RA through tissue engineering and immunomodulation.

Main Methods:

  • Literature review of stem cell biology and its application in joint diseases.
  • Analysis of MSC properties including differentiation, immunomodulation, and regenerative potential.
  • Discussion of MSC-based therapeutic strategies for OA and RA.

Main Results:

  • MSCs possess significant anti-inflammatory and immunosuppressive capabilities.
  • MSCs secrete factors that promote local tissue regeneration in situ.
  • MSC-based approaches show potential for cartilage tissue engineering and treating degenerative joint diseases.

Conclusions:

  • MSCs are valuable for tissue engineering and regenerative medicine in joint diseases.
  • The immunomodulatory and regenerative functions of MSCs can be harnessed for OA and RA therapy.
  • MSC-based cell therapy represents a promising strategy for managing osteoarthritis and rheumatoid arthritis.